Bio....stock charts of biotech companies awaiting approval/denial on their first products look a lot like AUPH. They get stuck in a trading range until the rumor mills begin....people spewing what they think they know. The NDA filing was recent, and we're in a finnicky market environment anyway. So we can't expect any pertinent news until the evaluations are complete. Just relax. Remember how impatient we became awaiting the Phase III results.